United States · Funded startup

Who invested in GPN Vaccines

2 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised this month

Funding summaryUpdated 5 Nov 2026

$10Braised across 2 rounds since 2025, from 2 sources

$3.5MRound$10BRound
Latest round
Round, $10BNov 2026
Step-upi
2857.1×
Investors
0
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2026
$3.5MRound$10BRound
First round
Round, $3.5M
Dec 2025
Biggest round
$10B
Round · Nov 2026
Between rounds
10 months
from the last two

The rounds

  1. Nov 2026
    Round$10B

    No investor was named in the report.

    Reported by Pulse 2.0

  2. Dec 2025
    Round$3.5M

    No investor was named in the report.

    Filed with the SEC (Form D); no report of this raise yetSEC filing: $3.5M sold, first sale Dec 2025

Founders and team

From GPN Vaccines's own website: 5 on the team.

  • Antiksha JoshiDirector of Quality
  • Malachi ObstResearch Officer
  • Miriam DoddQuality Manager
  • Peter MillsDirector of International
  • Shawn LuoResearch Officer

AdvisersMPhil Student

Quick answers about GPN Vaccines

How much has GPN Vaccines raised?

GPN Vaccines has raised $10B across 2 rounds since 2025.

When did GPN Vaccines last raise?

GPN Vaccines's most recent round, $10B, was in Nov 2026.

What was GPN Vaccines's biggest round?

Its most recent round, $10B in Nov 2026, is also its largest on record.

Where is GPN Vaccines based?

GPN Vaccines is based in the United States.

Companies like GPN Vaccines

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.